SCHEMBL938645

SCHEMBL938645

COc1cc(C)c(S(=O)(=O)N(C)Cc2nc3ccc(C(=O)O)cc3[nH]2)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.50
APEX1 P27695 1/20 0.48
CHEK2 O96017 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
HSP90AA1 P07900 1/20 0.47
ESR2 Q92731 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPK1 P28482 1/20 0.47
TOP2A P11388 1/20 0.45
PTPN1 P18031 1/20 0.44
F10 P00742 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2E1 P05181 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C8 P10632 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2B6 P20813 1/20 0.43
CYP2C19 P33261 1/20 0.43
DGAT1 O75907 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1017834 0.92 APEX1 (0.50) NPSR1APEX1CHEK2TDP1HSP90AA1
SCHEMBL939162 0.91 ALDH1A1 (0.46) CHEK2ALDH1A1MAPK1F10CYP2C9
SCHEMBL11888794 0.84 MAPT (0.45) APEX1ALDH1A1MAPK1F10CYP2C9
SCHEMBL941269 0.83 NPSR1 (0.47) NPSR1APEX1CHEK2TDP1HSP90AA1
SCHEMBL938644 0.81 NPSR1 (0.47) NPSR1APEX1CHEK2TDP1HSP90AA1
SCHEMBL1017833 0.80 APEX1 (0.49) NPSR1APEX1CHEK2TDP1HSP90AA1
SCHEMBL939863 0.79 BDKRB1 (0.38) ALDH1A1TP53SMN1; SMN2
SCHEMBL941264 0.79 KDM4C (0.41) TDP1ALDH1A1SMN1; SMN2
SCHEMBL938731 0.79 CYP3A4 (0.54) ALDH1A1MAPK1CYP1A2CYP3A4CYP2D6
SCHEMBL938582 0.77 ALDH1A1 (0.42) CHEK2TDP1ALDH1A1MAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles BDKRB1, BDKRB2, BRD1 NPSR1 228/4885APEX1 3873/4885CHEK2 978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.